首頁 › 潰瘍性結腸炎 › 德克薩斯州 › San Antonio
San Antonio, TX 的 潰瘍性結腸炎 臨床試驗
16 項針對 潰瘍性結腸炎 的研究正在 San Antonio（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
招募中3 期
- Southern Star Research Institute ( Site 0299), San Antonio
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
招募中2 期
- Southern Star Research Institute /ID# 280822, San Antonio
Confirmatory Clinical Study in Active Ulcerative Colitis
招募中2 期
- Southern Star Research Institute, San Antonio
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
招募中2 期
- Gastroenterology Research of San Antonio, San Antonio
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
招募中1/2 期歡迎健康志工
- Xencor Investigative Site, San Antonio
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
招募中2 期
- Site 002, San Antonio
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
招募中3 期
- Southern Star Research Institute, LLC, San Antonio
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
招募中3 期
- Gastroenterology Research of San Antonio, San Antonio
- Southern Star Research Institute, San Antonio
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
招募中2 期
- Southern Star Research Institute, San Antonio
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
招募中2 期
- Southern Star Research Institute, San Antonio
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
招募中2 期
- Southern Star Research Institute, San Antonio
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
招募中4 期
- Gastroenterology Research of San Antonio, LLC, San Antonio
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
招募中3 期
- Gastroenterology Research of San Antonio LLC - Site Number: 8400054, San Antonio
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
招募中3 期
- Southern Star Research Institute, LLC, San Antonio
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
招募中3 期
- Gastroenterology Research of San Antonio LLC - Site Number: 8400054, San Antonio
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
招募中觀察性研究
- Brooke Army Medical center, San Antonio
- Brooke Army Medical center, San Antonio
其他城市的 潰瘍性結腸炎 試驗
- New York City, NY23 項研究
- Orlando, FL22 項研究
- Miami, FL21 項研究
- Houston, TX17 項研究
- Chicago, IL15 項研究
- Tacoma, WA15 項研究
- San Diego, CA15 項研究
- Tyler, TX14 項研究
- Colorado Springs, CO14 項研究
- Los Angeles, CA13 項研究
- St. Louis, MO13 項研究
- Washington, DC12 項研究
San Antonio 的其他研究
- 非小細胞肺癌59 項研究
- 大腸直腸癌46 項研究
- 乳癌46 項研究
- 轉移性癌症44 項研究
- 癌症（所有類型）41 項研究
- 肥胖症40 項研究
- 第二型糖尿病37 項研究
- 過重34 項研究
- 卵巢癌31 項研究
- 胰臟癌31 項研究
- 前列腺癌28 項研究
- 子宮內膜癌27 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月5日。各研究自行設定資格標準；由研究團隊決定參與者資格。